HomeInsightsResults

Bharat Immunological & Biological Corporation Ltd Quarterly Result

Bharat Immunological & Biological Corporation Ltd Quarterly Result

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

57.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Bharat Immunological & Biological Corporation Ltd

NSE: BHARATIMMUNOLOG

Net Profit

₹ -4.92

Last updated on: Nov 24, 2024

Key Highlights

  • The revenue of Bharat Immunological & Biological Corporation Ltd for the Sep '23 is ₹ 0.16 crore as compare to the Jun '23 revenue of ₹ 0.1 crore. This represent the growth of 59.999996%.
  • The ebitda of Bharat Immunological & Biological Corporation Ltd for the Sep '23 is ₹ -4.52 crore as compare to the Jun '23 ebitda of ₹ -4.21 crore. This represent the growth of 7.363419%.
  • The net profit of Bharat Immunological & Biological Corporation Ltd for the Sep '23 is ₹ -4.92 crore as compare to the Jun '23 net profit of ₹ -4.59 crore. This represent the growth of 7.1895404%.

Results Analysis

Market Price of Bharat Immunological & Biological Corporation Ltd

1M

1Y

3Y

5Y

Monitoring Bharat Immunological & Biological Corporation Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202423.62
21 Nov 202423.06
19 Nov 202423.78
18 Nov 202423.33
14 Nov 202423.32
13 Nov 202423.51
12 Nov 202424.81
11 Nov 202425.22
08 Nov 202425.25
07 Nov 202425.91

Historical Revenue of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical EBITDA of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical Net Profit of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

10 Aug 202417:28

News

Bharat Immunological & Biolog.Corp. announces board meeting date

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

01 Mar 202410:22

News

Bharat Immunological & Biolog.Corp. to convene AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

29 Nov 202310:47

News

Bharat Immunological & Biolog.Corp. to conduct AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

28 Nov 202318:37

News

Bharat Immunological & Biolog.Corp. to conduct board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

20 Oct 202311:27

News

Bharat Immunological & Biolog.Corp. to convene board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

17 Apr 202316:28

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Bharat Immunological Biological Corporation Ltd Quarterly Result

What is the EPS of Bharat Immunological & Biological Corporation Ltd stock?

The Earnings Per Share (EPS) of Bharat Immunological & Biological Corporation Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Bharat Immunological & Biological Corporation Ltd EPS calculated?

The EPS of Bharat Immunological & Biological Corporation Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Bharat Immunological & Biological Corporation Ltd report its EPS?

Bharat Immunological & Biological Corporation Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Bharat Immunological & Biological Corporation Ltd EPS?

Factors that influence the EPS of Bharat Immunological & Biological Corporation Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Bharat Immunological & Biological Corporation Ltd EPS growth indicate future performance?

Yes, consistent growth in Bharat Immunological & Biological Corporation Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*